Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma

CDK inhibitors: positive and negative regulators of G1-phase progression

Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · see citing works

The retinoblastoma protein and cell cycle control

Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862 · see citing works

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649 · see citing works

The regulation of E2F by pRB-family proteins.

Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · see citing works

Effects of an Rb mutation in the mouse

Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755 · see citing works

Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis

Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C., Herrup, K., Lee, W., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,264 · see citing works

Retinoblastoma protein recruits histone deacetylase to repress transcription

Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1998) · Nature · doi:10.1038/35404 · Cited by 1,231 · see citing works

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1

Harbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057 · see citing works

Emerging roles of E2Fs in cancer: an exit from cell cycle control

Chen, H., Tsai, S., & Leone, G. W. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2696 · Cited by 1,019 · see citing works

The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy

Chu, I. M., Hengst, L., & Slingerland, J. M. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2347 · Cited by 986 · see citing works

Cellular mechanisms of tumour suppression by the retinoblastoma gene

Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974 · see citing works

Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation

Chen, P.-L., Scully, P., Shew, J.-Y., Wang, J. Y. J., & Lee, W.-H. (1989) · Cell · doi:10.1016/0092-8674(89)90517-5 · Cited by 952 · see citing works

Retinoblastoma protein represses transcription by recruiting a histone deacetylase

Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Levillain, J. P., Troalen, F., Trouche, D., & Harel‐Bellan, A. (1998) · Nature · doi:10.1038/35410 · Cited by 906 · see citing works

Cancer Incidence After Retinoblastoma

Wong, F. L. (1997) · JAMA · doi:10.1001/jama.278.15.1262 · Cited by 689 · see citing works

The ARF/p53 pathway.

Sherr, C. J., & Weber, J. D. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00038-6 · Cited by 654 · see citing works

Mad2 Overexpression Promotes Aneuploidy and Tumorigenesis in Mice

Sotillo, R., Hernando, E., Díaz-Rodríguez, E., Teruya-Feldstein, J., Cordón-Cardo, C., Lowe, S. W., & Benezra, R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.019 · Cited by 612 · see citing works

Pocket proteins and cell cycle control

Cobrinik, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208619 · Cited by 601 · see citing works

Inactivation of the p53 pathway in retinoblastoma

Laurie, N. A., Donovan, S. L., Shih, C.-S., Zhang, J., Mills, N., Fuller, C., Teunisse, A., Lam, S., Ramos, Y., Mohan, A., et al. (2006) · Nature · doi:10.1038/nature05194 · Cited by 595 · see citing works

A subset of p53-deficient embryos exhibit exencephaly

Sah, V. P., Attardi, L. D., Mulligan, G., Williams, B. O., Bronson, R. T., & Jacks, T. (1995) · Nature Genetics · doi:10.1038/ng0695-175 · Cited by 579 · see citing works

Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma

Eng, C., Li, F. P., Abramson, D. H., Ellsworth, R. M., Wong, F. L., Goldman, M., Seddon, J. M., Tarbell, N. J., & Boice, J. D. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.14.1121 · Cited by 567 · see citing works

Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control

Hernando, E., Nahlé, Z., Juan, G., Diaz-Rodriguez, E., Alaminos, M., Hemann, M., Michel, L., Mittal, V., Gerald, W., Benezra, R., et al. (2004) · Nature · doi:10.1038/nature02820 · Cited by 562 · see citing works

Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.

Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., & Donehower, L. A. (1993) · Nature Genetics · doi:10.1038/ng1193-225 · Cited by 542 · see citing works

Differential Phosphorylation of the Retinoblastoma Protein by G1/S Cyclin-dependent Kinases

Zarkowska, T., & Mittnacht, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12738 · Cited by 494 · see citing works

Intra-arterial Chemotherapy for the Management of Retinoblastoma

Gobin, Y. P. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.5 · Cited by 437 · see citing works

Extra-embryonic function of Rb is essential for embryonic development and viability

Wu, L., de Bruin, A., Saavedra, H. I., Starovic, M., Trimboli, A. J., Yang, Y., Opavska, J., Wilson, P. L., Thompson, J. C., Ostrowski, M. C., et al. (2003) · Nature · doi:10.1038/nature01417 · Cited by 382 · see citing works

p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2

Chu, I. M., Sun, J., Arnaout, A., Kahn, H., Hanna, W. M., Narod, S. A., Sun, P., Tan, C., Hengst, L., & Slingerland, J. M. (2007) · Cell · doi:10.1016/j.cell.2006.11.049 · Cited by 372 · see citing works

Intra-arterial Chemotherapy for Retinoblastoma

Yousef, Y. A., Soliman, S. E., Astudillo, P. P. P., Durairaj, P., Dimaras, H., Chan, H. S. L., Héon, E., Gallie, B. L., & Shaikh, F. (2016) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2016.0244 · Cited by 371 · see citing works

p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis

Kemp, C. J., Wheldon, T. E., & Balmain, A. (1994) · Nature Genetics · doi:10.1038/ng0994-66 · Cited by 366 · see citing works

Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma

Dimaras, H., Khetan, V., Halliday, W., Orlic, M., Prigoda, N. L., Piovesan, B., Marrano, P., Corson, T. W., Eagle, R. C., Squire, J. A., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn024 · Cited by 351 · see citing works

Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin

Gonzalo, S., García-Cao, M., Fraga, M. F., Schotta, G., Peters, A. H. F. M., Cotter, S. E., Eguía, R., Dean, D. C., Esteller, M., Jenuwein, T., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1235 · Cited by 343 · see citing works

Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth

Sellers, W. R., Novitch, B. G., Miyake, S., Heith, A., Otterson, G. A., Kaye, F. J., Lassar, A. B., & Kaelin, W. G. (1998) · Genes & Development · doi:10.1101/gad.12.1.95 · Cited by 343 · see citing works

Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth

Graña, X., Garriga, J., & Mayol, X. (1998) · Oncogene · doi:10.1038/sj.onc.1202575 · Cited by 328 · see citing works

Differential Regulation of Retinoblastoma Protein Function by Specific Cdk Phosphorylation Sites

Knudsen, E. S., & Wang, J. Y. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8313 · Cited by 320 · see citing works

p107 is a suppressor of retinoblastoma development in pRb-deficient micePreprint

Robanus-Maandag, E. C., Dekker, M., van der Valk, M., Carrozza, M. L., Jeanny, J., Dannenberg, J., Berns, A. J. M., & Riele, H. T. (1998) · Genes & Development · doi:10.1101/gad.12.11.1599 · Cited by 319 · see citing works

The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma

Yamane, T., Kaneko, A., & Mohri, M. (2004) · International Journal of Clinical Oncology · doi:10.1007/s10147-004-0392-6 · Cited by 317 · see citing works

Lifetime Risks of Common Cancers Among Retinoblastoma Survivors

Fletcher, O., Easton, D. F., Anderson, K., Gilham, C., Jay, M., & Peto, J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh058 · Cited by 311 · see citing works

p27 binds cyclin–CDK complexes through a sequential mechanism involving binding-induced protein folding

Lacy, E. R., Filippov, I. V., Lewis, W. S., Otieno, S. B., Xiao, L., Weiß, S. B., Hengst, L., & Kriwacki, R. W. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb746 · Cited by 305 · see citing works

Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53.Preprint

Howes, K. A., Ransom, N. L., Papermaster, D. S., Lasudry, J., Albert, D. M., & Windle, J. J. (1994) · Genes & Development · doi:10.1101/gad.8.11.1300 · Cited by 298 · see citing works

Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma

Chen, D., Livne-bar, I., Vanderluit, J. L., Slack, R. S., Agochiya, M., & Bremner, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.025 · Cited by 281 · see citing works

One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma

Corson, T. W., & Gallie, B. L. (2007) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20457 · Cited by 278 · see citing works

Retinoblastoma Has Properties of a Cone Precursor Tumor and Depends Upon Cone-Specific MDM2 Signaling

Xu, X. L., Fang, Y., Lee, T. C., Forrest, D., Gregory, C. Y., Almeida, D., Liu, A., Jhanwar, S. C., Abramson, D. H., & Cobrinik, D. E. (2009) · Cell · doi:10.1016/j.cell.2009.03.051 · Cited by 246 · see citing works

Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim

Zhao, Y., Tan, J. Y., Zhuang, L., Jiang, X., Liu, E. T., & Yu, Q. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505585102 · Cited by 246 · see citing works

Retinoblastoma in transgenic mice

Windle, J. J., Albert, D. M., O’Brien, J. M., Marcus, D. M., Distèche, C. M., Bernards, R., & Mellon, P. L. (1990) · Nature · doi:10.1038/343665a0 · Cited by 239 · see citing works

Loss of pRB causes centromere dysfunction and chromosomal instabilityPreprint

Manning, A. L., Longworth, M. S., & Dyson, N. J. (2010) · Genes & Development · doi:10.1101/gad.1917310 · Cited by 238 · see citing works

The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression.

DeCaprio, J. A., Furukawa, Y., Ajchenbaum, F., Griffin, J. D., & Livingston, D. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1795 · Cited by 233 · see citing works

RB-Dependent S-Phase Response to DNA Damage

Knudsen, K. E., Booth, D., Naderi, S., Sever-Chroneos, Z., Fribourg, A. F., Hunton, I. C., Feramisco, J. R., Wang, J. Y. J., & Knudsen, E. S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7751-7763.2000 · Cited by 224 · see citing works

Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter.

Al‐Ubaidi, M. R., Font, R. L., Quiambao, A. B., KEENER, M. J., Liou, G. I., Overbeek, P. A., & Baehr, W. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.119.6.1681 · Cited by 224 · see citing works

Secondary Acute Myelogenous Leukemia in Patients with Retinoblastoma

Gombos, D. S., Hungerford, J. L., Abramson, D. H., Kingston, J. E., Chantada, G. L., Dunkel, I. J., Antoneli, C. B. G., Greenwald, M. J., Haik, B. G., Leal, C. A., et al. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.074 · Cited by 209 · see citing works

Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators

Canturk, S., Qaddoumi, I. A., Khetan, V., Ma, Z., Furmanchuk, A. V., Antoneli, C. B. G., Sultan, I. Y., Kebudi, R., Sharma, T., Galindo, C. R., et al. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.168062 · Cited by 209 · see citing works

Survival with retinoblastoma in the USA: 1975-2004

Broaddus, E., Topham, A., & Singh, A. D. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.143842 · Cited by 200 · see citing works

A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma

Abramson, D. H., Frank, C. M., & Dunkel, I. J. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90406-2 · Cited by 200 · see citing works

Intra-arterial Chemotherapy for Retinoblastoma

Shields, C. L. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.150 · Cited by 200 · see citing works

Oncogenesis of the Lens in Transgenic Mice

Mahon, K. A., Chepelinsky, A. B., Khillan, J. S., Overbeek, P. A., Piatigorsky, J., & Westphal, H. (1987) · Science · doi:10.1126/science.3029873 · Cited by 194 · see citing works

The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer

Bosco, E. E., Wang, Y., Xu, H., Zilfou, J. T., Knudsen, K. E., Aronow, B. J., Lowe, S. W., & Knudsen, E. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28803 · Cited by 192 · see citing works

KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers

Corson, T. W., Huang, A., Tsao, M., & Gallie, B. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208641 · Cited by 184 · see citing works

TOPOISOMERASE II INHIBITOR‐RELATED ACUTE MYELOID LEUKAEMIA

Pui, C., & Relling, M. V. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01843.x · Cited by 181 · see citing works

Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit

Binné, U. K., Classon, M. K., Dick, F. A., Wei, W., Rape, M., Kaelin, W. G., Näär, A. M., & Dyson, N. J. (2007) · Nature Cell Biology · doi:10.1038/ncb1532 · Cited by 175 · see citing works

Rb and p130 control cell cycle gene silencing to maintain the postmitotic phenotype in cardiac myocytes

Sdek, P., Zhao, P., Wang, Y., Huang, C.-J., Ko, C. Y., Butler, P. C., Weiss, J. N., & MacLellan, W. R. (2011) · The Journal of Cell Biology · doi:10.1083/jcb.201012049 · Cited by 175 · see citing works

An Rb-Skp2-p27 Pathway Mediates Acute Cell Cycle Inhibition by Rb and Is Retained in a Partial-Penetrance Rb Mutant

Ji, P., Jiang, H., Rekhtman, K., Bloom, J., Ichetovkin, M., Pagano, M., & Zhu, L. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.09.029 · Cited by 170 · see citing works

Strategies to manage retinoblastoma in developing countries

Chantada, G. L., Qaddoumi, I. A., Canturk, S., Khetan, V., Ma, Z., Kimani, K., Yeniad, B., Sultan, I. Y., Sitorus, R. S., Taçyıldız, N., et al. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22843 · Cited by 166 · see citing works

Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation

Xiao, B., SPENCER, J. M., Clements, A. M., Ali‐Khan, N., Mittnacht, S., Broceño, C., Burghammer, M. C., Anastassis Perrakis, A., Marmorstein, R., & Gamblin, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0436813100 · Cited by 158 · see citing works

Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice.

Al‐Ubaidi, M. R., Hollyfield, J. G., Overbeek, P. A., & Baehr, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1194 · Cited by 148 · see citing works

Division and apoptosis of E2f-deficient retinal progenitors

Chen, D., Pacal, M., Wenzel, P., Knoepfler, P. S., Leone, G., & Bremner, R. (2009) · Nature · doi:10.1038/nature08544 · Cited by 144 · see citing works

Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay.

Inomata, M., & Kaneko, A. (1987) · PubMed · Cited by 142 · see citing works

Activity of the Retinoblastoma Family Proteins, pRB, p107, and p130, during Cellular Proliferation and Differentiation

Sidle, A., Palaty, C., Dirks, P., Wiggan, O., Kiess, M., Gill, R. M., Wong, A. K., & Hamel, P. A. (1996) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239609106585 · Cited by 141 · see citing works

Intra-arterial Chemotherapy for Retinoblastoma

Shields, C. L. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.151 · Cited by 140 · see citing works

Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells.

Furukawa, Y., DeCaprio, J. A., Freedman, A. S., Kanakura, Y., Nakamura, M., Ernst, T. J., Livingston, D. M., & Griffin, J. D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2770 · Cited by 139 · see citing works

Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer

DiCiommo, D. P., Gallie, B. L., & Bremner, R. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0326 · Cited by 137 · see citing works

Proapoptotic Function of the Retinoblastoma Tumor Suppressor Protein

Ianari, A., Natale, T., Calo, E., Ferretti, E., Alesse, E., Screpanti, I., Haigis, K. M., Gulino, A., & Lees, J. A. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.026 · Cited by 135 · see citing works

Melanoma Proliferation and Chemoresistance Controlled by the DEK Oncogene

Khodadoust, M. S., Verhaegen, M. E., Kappes, F., Riveiro‐Falkenbach, E., Cigudosa, J. C., Kim, D. S. L., Chinnaiyan, A. M., Markovitz, D. M., & Soengas, M. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1063 · Cited by 135 · see citing works

Chemotherapy for Retinoblastoma

Chan, H. Y. E., Gallie, B. L., Munier, F. L., & Popovic, M. B. (2005) · Ophthalmology Clinics of North America · doi:10.1016/j.ohc.2004.11.002 · Cited by 135 · see citing works

Second primary tumors in patients with hereditary retinoblastoma: A register-based follow-up study, 1945–1994

Moll, A. C., Imhof, S. M., Bouter, L. M., Kuik, D. J., Otter, W. D., Bezemer, P. D., Koten, J. W., & Tan, K. E. W. P. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960807)67:4 · Cited by 131 · see citing works

Apoptosis Inhibition by the Human DEK Oncoprotein Involves Interference with p53 Functions

Wise-Draper, T. M., Allen, H. V., Jones, E. E., Habash, K. B., Matsuo, H., & Wells, S. I. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00430-06 · Cited by 128 · see citing works

The Retinoblastoma Protein Regulates Pericentric Heterochromatin

Isaac, C. E., Francis, S. M., Martens, A. L., Julian, L. M., Seifried, L. A., Erdmann, N., Binné, U. K., Harrington, L., Sicinski, P., Bérubé, N. G., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3659-3671.2006 · Cited by 128 · see citing works

A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma

Squire, J. A., Gallie, B. L., & Phillips, R. A. (1985) · Human Genetics · doi:10.1007/bf00295364 · Cited by 128 · see citing works

Ocular Motility Changes After Subtenon Carboplatin Chemotherapy for Retinoblastoma

Mulvihill, A. O. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.8.1120 · Cited by 125 · see citing works

Molecular Basis of Low-Penetrance Retinoblastoma

Harbour, J. W. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.11.1699 · Cited by 123 · see citing works

RBF1 promotes chromatin condensation through a conserved interaction with the Condensin II protein dCAP-D3

Longworth, M. S., Herr, A., Ji, J.-Y., & Dyson, N. J. (2008) · Genes & Development · doi:10.1101/gad.1631508 · Cited by 122 · see citing works

Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death

Garner, E., & Raj, K. (2008) · Cell Cycle · doi:10.4161/cc.7.3.5328 · Cited by 119 · see citing works

Overview of rb gene mutations in patients with retinoblastoma

Harbour, J. W. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)98025-3 · Cited by 117 · see citing works

The Human DEK Proto-Oncogene Is a Senescence Inhibitor and an Upregulated Target of High-Risk Human Papillomavirus E7

Wise-Draper, T. M., Allen, H. V., Thobe, M. N., Jones, E. E., Habash, K. B., Münger, K., & Wells, S. I. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14309-14317.2005 · Cited by 117 · see citing works

Pre- and postconception factors associated with sporadic heritable and nonheritable retinoblastoma.

Bunin, G., Meadows, A. T., Bs, E., Jd, B., Wg, W., & Gd, H. (1989) · PubMed · Cited by 115 · see citing works

Profiling genomic copy number changes in retinoblastoma beyond loss of RB1

Bowles, E., Corson, T. W., Bayani, J., Squire, J. A., Wong, N., Lai, P. B. S., & Gallie, B. L. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20383 · Cited by 110 · see citing works

Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation

Pickering, M. T., & Kowalik, T. F. (2006) · Oncogene · doi:10.1038/sj.onc.1209103 · Cited by 108 · see citing works

DEK Is a Poly(ADP-Ribose) Acceptor in Apoptosis and Mediates Resistance to Genotoxic Stress

Kappes, F., Fahrer, J., Khodadoust, M. S., Tabbert, A., Strasser, C., Mor‐Vaknin, N., Moreno‐Villanueva, M., Bürkle, A., Markovitz, D. M., & Ferrando‐May, E. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01921-07 · Cited by 107 · see citing works

Compensation by tumor suppressor genes during retinal development in mice and humans

Donovan, S. L., Schweers, B. A., Martins, R. A. P., Johnson, D. A., & Dyer, M. A. (2006) · BMC Biology · doi:10.1186/1741-7007-4-14 · Cited by 104 · see citing works

The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.

Fan, G., Ma, X., Kren, B. J., & Steer, C. J. (1996) · PubMed · Cited by 104 · see citing works

Role of pRB dephosphorylation in cell cycle regulation

Tamrakar, S. (2000) · Frontiers in bioscience · doi:10.2741/tamrakar · Cited by 101 · see citing works

Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors

Peterson, E. C., Elhammady, M. S., Quintero-Wolfe, S., Murray, T. G., & Aziz‐Sultan, M. A. (2011) · Journal of neurosurgery · doi:10.3171/2011.1.jns10466 · Cited by 98 · see citing works

Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a

Brennan, R. C., Federico, S. M., Bradley, C. L., Zhang, J., Flores‐Otero, J., Wilson, M. W., Stewart, C. F., Zhu, F., Guy, K., & Dyer, M. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0058 · Cited by 97 · see citing works

Ischemic Necrosis and Atrophy of the Optic Nerve After Periocular Carboplatin Injection for Intraocular Retinoblastoma

Schmack, I., Hubbard, G. B., Kang, S. J., Aaberg, T. M., & Grossniklaus, H. E. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.02.044 · Cited by 96 · see citing works

pRb: master of differentiation. Coupling irreversible cell cycle withdrawal with induction of muscle-specific transcription

Falco, G. D., Comes, F., & Simone, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209623 · Cited by 93 · see citing works

Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressorPreprint

Liu, X., & Marmorstein, R. (2007) · Genes & Development · doi:10.1101/gad.1590607 · Cited by 92 · see citing works

Frontiers in the Management of Retinoblastoma

Lin, P., & O’Brien, J. M. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.04.004 · Cited by 89 · see citing works

Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma

Mutapcic (2011) · Clinical ophthalmology · doi:10.2147/opth.s12665 · Cited by 83 · see citing works

DEK proto-oncogene expression interferes with the normal epithelial differentiation program.

Wise-Draper, T. M., Morreale, R. J., Morris, T., Mintz-Cole, R. A., Hoskins, E. E., Balsitis, S., Husseinzadeh, N., Witte, D., Wikenheiser-Brokamp, K., Lambert, P., et al. (2009) · American Journal of Pathology · doi:10.2353/ajpath.2009.080330 · Cited by 82 · see citing works

Structure-function analysis of the retinoblastoma tumor suppressor protein – is the whole a sum of its parts?

Dick, F. A. (2007) · Cell Division · doi:10.1186/1747-1028-2-26 · Cited by 79 · see citing works

Commitment to a Cellular Transition Precedes Genome-wide Transcriptional Change

Eser, U., Falleur-Fettig, M., Johnson, A., & Skotheim, J. M. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.024 · Cited by 77 · see citing works

Nuclear Exclusion of Wild-Type p53 in Immortalized Human Retinoblastoma Cells

Schlamp, C. L., Poulsen, G. L., Nork, T. M., & Nickells, R. W. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.20.1530 · Cited by 75 · see citing works

Evaluation of the In vitro and In vivo Antitumor Activity of Histone Deacetylase Inhibitors for the Therapy of Retinoblastoma

Dalgard, C. L., Quill, K. R. V., & O’Brien, J. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4836 · Cited by 74 · see citing works

p53 facilitates pRb cleavage in IL‐3‐deprived cells: novel pro‐apoptotic activity of p53

Gottlieb, E., & Oren, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3587 · Cited by 73 · see citing works

Retinoblastoma Pathway Defects Show Differential Ability to Activate the Constitutive DNA Damage Response in Human Tumorigenesis

Tort, F., Bártková, J., Sehested, M., Orntoft, T. F., Lukas, J., & Bártek, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2178 · Cited by 66 · see citing works

A cell‐autonomous requirement for the cell cycle regulatory protein, Rb, in neuronal migration

Ferguson, K. L., McClellan, K. A., Vanderluit, J. L., McIntosh, W. C., Schuurmans, C., Polleux, F., & Slack, R. S. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600887 · Cited by 65 · see citing works

External Beam Radiotherapy in Retinoblastoma

Scott, I. U. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.6.766 · Cited by 62 · see citing works

Severe ocular abnormalities in C57BL/6 but not in 129/Sv p53-deficient mice.

Ikeda, S., Hawes, N. L., Chang, B., Avery, C., Smith, R. S., & Nishina, P. M. (1999) · PubMed · Cited by 60 · see citing works

Ototoxicity of carboplatin: comparing animal and clinical models at the Hospital for Sick Children.

MacDonald, M. R. A., Harrison, R. V., Wake, M., Bliss, B., & Macdonald, R. (1994) · PubMed · Cited by 60 · see citing works

The Rb pathway in neurogenesis

Ferguson, K. L., & Slack, R. S. (2001) · Neuroreport · doi:10.1097/00001756-200107030-00001 · Cited by 57 · see citing works

Genomic gains on chromosome 1q in retinoblastoma: Consequences on gene expression and association with clinical manifestation

Kappler‐Gratias, S., Schüler, A., Hitpaß, L., Stephan, H., Rieder, H., Schneider, S., Horsthemke, B., & Lohmann, D. R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21051 · Cited by 57 · see citing works

A Skp2 autoinduction loop and restriction point control

Yung, Y., Walker, J. L., Roberts, J. M., & Assoian, R. K. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703034 · Cited by 52 · see citing works

Loss of Retinoblastoma Tumor Suppressor Protein Makes Human Breast Cancer Cells More Sensitive to Antimetabolite Exposure

Derenzini, M., Donati, G., Mazzini, G., Montanaro, L., Vici, M., Ceccarelli, C., Santini, D., Taffurelli, M., & Treré, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2065 · Cited by 52 · see citing works

E2F1 induces MRN foci formation and a cell cycle checkpoint response in human fibroblasts

Frame, F. M., Rogoff, H. A., Pickering, M., Cress, W. D., & Kowalik, T. F. (2006) · Oncogene · doi:10.1038/sj.onc.1209352 · Cited by 49 · see citing works

The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase.

Suzuki‐Takahashi, I., Kitagawa, M., Saijo, M., Higashi, H., Ogino, H., Matsumoto, H., Taya, Y., Nishimura, S., & Okuyama, A. (1995) · PubMed · Cited by 45 · see citing works

Revisiting Old Drugs as Novel Agents for Retinoblastoma: In Vitro and In Vivo Antitumor Activity of Cardenolides

Antczak, C., Kloepping, C., Radu, C., Genski, T., ̈ller-Kuhrt, L. M., Siems, K., de Stanchina, E., Abramson, D. H., & Djaballah, H. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3158 · Cited by 44 · see citing works

RB Restricts DNA Damage-Initiated Tumorigenesis through an LXCXE-Dependent Mechanism of Transcriptional Control

Bourgo, R. J., Thangavel, C., Ertel, A., Bergseid, J., McClendon, A. K., Wilkens, L., Witkiewicz, A. K., Wang, J. Y. J., & Knudsen, E. S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.029 · Cited by 42 · see citing works

Severe pseudo–preseptal cellulitis following sub–Tenon’s carboplatin injection for intraocular retinoblastoma

Kıratlı, H., Kocabeyoğlu, S., & Bilgiç, S. (2007) · Journal of American Association for Pediatric Ophthalmology and Strabismus · doi:10.1016/j.jaapos.2006.11.005 · Cited by 39 · see citing works

Topotecan Triggers Apoptosis in p53-Deficient Cells by Forcing Degradation of XIAP and Survivin Thereby Activating Caspase-3-Mediated Bid Cleavage

Tomicic, M. T., Christmann, M., & Kaina, B. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.159962 · Cited by 37 · see citing works

Expression of p14, MDM2, and MDM4 in human retinoblastoma

Guo, Y., Pajovic, S., & Gallie, B. L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.055 · Cited by 36 · see citing works

Analysis of the Rb Gene and Cyclin-Dependent Kinase 4 Inhibitor Genes (p16INK4and p15INK4B) in Human Ovarian Carcinoma Cell Lines

Yaginuma, Y., Hayashi, H., Kawai, K., Kurakane, T., Saitoh, Y., Kitamura, S., Sengoku, K., & Ishikawa, M. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3560 · Cited by 32 · see citing works

EDWARD COTLIER AND ROBERT WEINREB, EDITORS Retinoblastoma in Transgenic Mice

Mills, M. D., Windle, J. J., & Albert, D. M. (1999) · Survey of Ophthalmology · doi:10.1016/s0039-6257(99)00047-8 · Cited by 32 · see citing works

The Oncogene DEK Promotes Leukemic Cell Survival and Is Downregulated by both Nutlin-3 and Chlorambucil in B-Chronic Lymphocytic Leukemic Cells

Secchiero, P., Voltan, R., di Iasio, M. G., Melloni, E., Tiribelli, M., & Zauli, G. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3031 · Cited by 27 · see citing works

Histopathologic Findings of Eyes Enucleated After Treatment with Chemosurgery for Retinoblastoma

Graeber, C. P., Gobin, Y. P., Marr, B. P., Dunkel, I. J., Brodie, S. E., Bornfeld, N., Char, D. H., Folberg, R., Imhof, S. M., Lin, A., et al. (2011) · The Open Ophthalmology Journal · doi:10.2174/1874364101105010001 · Cited by 25 · see citing works

When viral oncoprotein meets tumor suppressor: a structural viewPreprint

Liu, X., & Marmorstein, R. (2006) · Genes & Development · doi:10.1101/gad.1471706 · Cited by 24 · see citing works

Ten novel RB1 gene mutations in patients with retinoblastoma.

Abouzeid, H., Munier, F. L., Thonney, F., & Schorderet, D. F. (2007) · PubMed · Cited by 23 · see citing works

Trilateral tumors in four different lines of transgenic mice expressing SV40 T-antigen.

Marcus, D. M., Lasudry, J., Carpenter, J. L., Windle, J. J., Howes, K. A., Al‐Ubaidi, M. R., Baehr, W., Overbeek, P. A., Font, R. L., & Albert, D. M. (1996) · PubMed · Cited by 23 · see citing works

Retinoblastoma: Animal Models

Conway, R. M., WHEELER, S., MURRAY, T., Jockovich, M. E., & OBRIEN, J. (2005) · Ophthalmology Clinics of North America · doi:10.1016/j.ohc.2004.08.006 · Cited by 18 · see citing works

Intra-arterial and Oral Digoxin Therapy for Retinoblastoma

Patel, M. M., Paulus, Y. M., Gobin, Y. P., Djaballah, H., Marr, B. P., Dunkel, I. J., Brodie, S. E., Antczak, C., Folberg, R., & Abramson, D. H. (2011) · Ophthalmic Genetics · doi:10.3109/13816810.2010.544530 · Cited by 18 · see citing works

A cancer derived mutation in the Retinoblastoma gene with a distinct defect for LXCXE dependent interactions

Henley, S. A., Francis, S. M., Demone, J., Ainsworth, P., & Dick, F. A. (2010) · Cancer Cell International · doi:10.1186/1475-2867-10-8 · Cited by 9 · see citing works

The Retinoblastoma Tumor Suppressor Regulates a Xenobiotic Detoxification Pathway

Robles, M. T. S., Case, A., Chong, J.-L., Leone, G. W., & Pipas, J. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026019 · Cited by 5 · see citing works

Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells

Kang, J., Sergio, C. M., Sutherland, R. L., & Musgrove, E. A. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-32 · Cited by 147 · see citing works

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

Pascual-Pasto, G., Bazan-Peregrino, M., Olaciregui, N. G., Restrepo-Perdomo, C. A., Mato-Berciano, A., Ottaviani, D., Weber, K., Correa, G., Paco, S., Vila-Ubach, M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat9321 · Cited by 118 · see citing works

Retinoblastoma: Etiology, Modeling, and Treatment

Kaewkhaw, R., & Rojanaporn, D. (2020) · Cancers · doi:10.3390/cancers12082304 · Cited by 108 · see citing works

Mitochondrial glutamine metabolism via GOT2 supports pancreatic cancer growth through senescence inhibition

Yang, S., Hwang, S., Kim, M., Seo, S. B., Lee, J., & Jeong, S. M. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0089-1 · Cited by 106 · see citing works

Advancing Precision Medicine for Prostate Cancer Through Genomics

Roychowdhury, S., & Chinnaiyan, A. M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.3662 · Cited by 88 · see citing works

Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy

Zhu, K., Dai, Z., & Zhou, J. (2013) · Biomarker Research · doi:10.1186/2050-7771-1-10 · Cited by 78 · see citing works

Retinoblastoma: present scenario and future challenges

Byroju, V. V., Nadukkandy, A. S., Cordani, M., & Kumar, L. D. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01223-z · Cited by 77 · see citing works

Spectrum of RB1 mutations identified in 403 retinoblastoma patients

Price, E. A., Price, K., Kolkiewicz, K., Hack, S., Reddy, M. A., Hungerford, J. L., Kingston, J. E., & Onadim, Z. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101821 · Cited by 75 · see citing works

Posttranslational Modifications of the Retinoblastoma Tumor Suppressor Protein as Determinants of Function

MacDonald, J. I., & Dick, F. A. (2012) · Genes & Cancer · doi:10.1177/1947601912473305 · Cited by 69 · see citing works

Post-translational modifications on the retinoblastoma protein

Zhou, L., Ng, D. S., Yam, J. C. S., Chen, L. J., Tham, C. C. Y., Pang, C. P., & Chu, W. K. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00818-x · Cited by 64 · see citing works

Clinical use of photodynamic therapy in ocular tumors

Çerman, E., & Çekıç, O. (2015) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2015.05.004 · Cited by 64 · see citing works

Therapeutic Options for Retinoblastoma

Mendoza, P. R., & Grossniklaus, H. E. (2016) · Cancer Control · doi:10.1177/107327481602300203 · Cited by 64 · see citing works

BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer

Hu, F., Meng, X., Tong, Q., Liang, L., Xiang, R., Zhu, T., & Yang, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.011 · Cited by 58 · see citing works

Therapeutic potential of curcumin in major retinal pathologies

Peddada, K. V., Brown, A., Verma, V., & Nebbioso, M. (2018) · International Ophthalmology · doi:10.1007/s10792-018-0845-y · Cited by 56 · see citing works

Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma

Pritchard, E. M., Dyer, M. A., & Guy, R. K. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666150722100610 · Cited by 55 · see citing works

Proton Radiation Therapy for the Treatment of Retinoblastoma

Mouw, K. W., Sethi, R. V., Yeap, B. Y., MacDonald, S. M., Chen, Y.-L. E., Tarbell, N. J., Yock, T. I., Munzenrider, J. E., Adams, J., Grabowski, E. F., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.07.031 · Cited by 54 · see citing works

An Introduction to Fundamentals of Cancer Biology

Sriharikrishnaa, S., Suresh, P. S., & Kabekkodu, S. P. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-031-31852-8_11 · Cited by 50 · see citing works

Osteosarcoma: prognosis plateau warrants retinoblastoma pathway targeted therapy

Ballatori, S. E., & Hinds, P. W. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2016.1 · Cited by 44 · see citing works

In vitro characterization of CD133lo cancer stem cells in Retinoblastoma Y79 cell line

Nair, R. M., Balla, M. M. S., Khan, I., Kalathur, R. K. R., Kondaiah, P., & Vemuganti, G. K. (2017) · BMC Cancer · doi:10.1186/s12885-017-3750-2 · Cited by 39 · see citing works

Role of RB1 in human embryonic stem cell-derived retinal organoids

Zheng, C., Schneider, J. W., & Hsieh, J. (2020) · Developmental Biology · doi:10.1016/j.ydbio.2020.03.011 · Cited by 37 · see citing works

Cell cycle-related kinase in carcinogenesis

Tian, Y., WAN, H., & Tan, G. (2012) · Oncology Letters · doi:10.3892/ol.2012.828 · Cited by 35 · see citing works

Next-Generation Technologies and Strategies for the Management of Retinoblastoma

Gudiseva, H. V., Berry, J. L., Polski, A., Tummina, S. J., & O’Brien, J. M. (2019) · Genes · doi:10.3390/genes10121032 · Cited by 32 · see citing works

Notch2 suppression mimicking changes in human pulmonary hypertension modulates Notch1 and promotes endothelial cell proliferation

Sahoo, S., Li, Y., de Jesus, D. S., Sembrat, J., Rojas, M. M., Goncharova, E. A., Cifuentes-Pagano, E., Straub, A. C., & Pagano, P. J. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00125.2021 · Cited by 30 · see citing works

Long non-coding RNA MALAT1 aggravates human retinoblastoma by sponging miR-20b-5p to upregulate STAT3

Wang, L., Zhang, Y., & Xin, X. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152977 · Cited by 27 · see citing works

Evolution of Care of Orbital Tumors with Radiation Therapy

Ioakeim‐Ioannidou, M., & MacDonald, S. M. (2020) · Journal of Neurological Surgery Part B Skull Base · doi:10.1055/s-0040-1713894 · Cited by 24 · see citing works

Suppression of PAX6 promotes cell proliferation and inhibits apoptosis in human retinoblastoma cells

Meng, B., Wang, Y., & Li, B. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1812 · Cited by 24 · see citing works

The Retinoblastoma Tumor Suppressor Modulates DNA Repair and Radioresponsiveness

Thangavel, C., Boopathi, E., Ciment, S., Liu, Y., Neill, R. O., Sharma, A. M., McMahon, S. B., Mellert, H. S., Addya, S., Ertel, A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0326 · Cited by 24 · see citing works

Second hit impels oncogenesis of retinoblastoma in patient-induced pluripotent stem cell-derived retinal organoids: direct evidence for Knudson's theory

Li, Y.-P., Wang, Y., Wang, W., Zhang, X., Shen, R., Jin, K., Jin, L., & Jin, Z. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac162 · Cited by 23 · see citing works

SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma

Chen, X., Kunda, P. E., Lin, J., Zhou, M., Huang, J., Zhang, H., & Liu, T. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2584-x · Cited by 23 · see citing works

Optical coherence tomography enables imaging of tumor initiation in the TAg-RB mouse model of retinoblastoma.

Wenzel, A., O’Hare, M., Shadmand, M., & Corson, T. W. (2015) · PubMed Central · Cited by 23 · see citing works

Neuron-NG2 Cell Synapses: Novel Functions for Regulating NG2 Cell Proliferation and Differentiation

Yang, Q., Xiong, J., & Yao, Z. (2013) · BioMed Research International · doi:10.1155/2013/402843 · Cited by 21 · see citing works

Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma

Singh, L., Singh, M. K., Rizvi, M. M. A., Bakhshi, S., Meel, R., Lomi, N., Sen, S., & Kashyap, S. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02529-4 · Cited by 20 · see citing works

Retinoblastoma: An update on genetic origin, classification, conventional to next-generation treatment strategies

Pareek, A., Kumar, D., Pareek, A., Gupta, M. M., Jeandet, P., Ratan, Y., Jain, V., Kamal, M. A., Saboor, M., Ashraf, G. M., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32844 · Cited by 20 · see citing works

Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T Cells

Pascual‐Pasto, G., McIntyre, B. C., Giudice, A. M., Alikarami‬, F., Morrissey, A., Matlaga, S., Hofmann, T. J., Burgueño, V., Harvey, K., Martínez, D., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-0221 · Cited by 18 · see citing works

Animal models in retinoblastoma research

Nair, R. M., Kaliki, S., & Vemuganti, G. K. (2013) · Saudi Journal of Ophthalmology · doi:10.1016/j.sjopt.2013.06.008 · Cited by 18 · see citing works

Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma

Ma, H., Nie, C., Chen, Y., Li, J., Xie, Y., Tang, Z., Gao, Y., Ai, S., Mao, Y., Sun, Q., et al. (2021) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504021x16130322409507 · Cited by 17 · see citing works

Immunotherapies of retinoblastoma: Effective methods for preserving vision in the future

Wang, L., Li, S., Mei, J., & Ye, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.949193 · Cited by 17 · see citing works

Smart Nanocarriers for the Treatment of Retinal Diseases

Liu, S., Yan, Z., Huang, Z., Yang, H., & Li, J. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c01289 · Cited by 16 · see citing works

Paediatric Retinoblastoma in India: Evidence from the National Cancer Registry Programme

Rangamani, S., Sathishkumar, K., Manoharan, N., Julka, P. K., Rath, G. K., Shanta, V., Swaminathan, R., Rama, R., Datta, K., Mandal, S., et al. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.10.4193 · Cited by 16 · see citing works

Tumor heterogeneity in retinoblastoma: a literature review

Pallavi, R., Soni, B. L., Jha, G. K., Sanyal, S., Fatima, A., & Kaliki, S. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10263-5 · Cited by 13 · see citing works

Integrated Analysis of Dysregulated miRNA-Gene Expression in HMGA2 -Silenced Retinoblastoma Cells

Venkatesan, N., Deepa, P. R., Vasudevan, M., Khetan, V., Reddy, M. A., & Krishnakumar, S. (2014) · Bioinformatics and Biology Insights · doi:10.4137/bbi.s16958 · Cited by 13 · see citing works

Downregulation of Nodal inhibits metastatic progression in retinoblastoma

Asnaghi, L., White, D. T., Yoon, L., Price, A. C., Lee, G. Y., Sahoo, A., Mumm, J. S., & Eberhart, C. G. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0785-4 · Cited by 12 · see citing works

Long-term audiologic follow-up of carboplatin-treated children with retinoblastoma

Geurtsen, M. L., Kors, W. A., Moll, A. C., & Smits, C. (2016) · Ophthalmic Genetics · doi:10.3109/13816810.2015.1137325 · Cited by 10 · see citing works

Beyond What Your Retina Can See: Similarities of Retinoblastoma Function between Plants and Animals, from Developmental Processes to Epigenetic Regulation

Zluhan‐Martínez, E., Pérez‐Koldenkova, V., Ponce-Castañeda, M. V., Sánchez, M. D. L. P., García‐Ponce, B., Miguel-Hernández, S., Alvarez-Buylla, E. R., & Garay‐Arroyo, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144925 · Cited by 10 · see citing works

Na+/Ca2+ Exchanger a Druggable Target to Promote β-Cell Proliferation and Function

Papin, J., Zummo, F. P., Pachera, N., Guay, C., Regazzi, R., Cardozo, A. K., & Herchuelz, A. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2017-00370 · Cited by 9 · see citing works

Advances in the genetics of eye diseases

Chan, S., Freund, P. R., & MacDonald, I. M. (2013) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000026 · Cited by 9 · see citing works

Identification of co‑expression modules and hub genes of retinoblastoma via co‑expression analysis and protein‑protein interaction networks

Mao, Y., Nie, Q., Yang, Y., & Mao, G. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11189 · Cited by 9 · see citing works

Histone Deacetylases in Retinoblastoma

Lisek, M., Tomczak, J., Swiatek, J., Kaluza, A., & Boczek, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136910 · Cited by 7 · see citing works

Immunohistochemical assay for neuron-specific enolase, synaptophysin, and RB-associated protein as a diagnostic aid in advanced retinoblastomas

López, J., Alonso, N. F., Álvarez, J. C., García‐Caballero, T., & Jimeno, J. C. P. (2018) · Clinical ophthalmology · doi:10.2147/opth.s141503 · Cited by 6 · see citing works

Molecular Genetics of Cancer

Chuphal, B. (2022) · Springer eBooks · doi:10.1007/978-981-16-7041-1_18 · Cited by 4 · see citing works

Genomic landscape of retinoblastoma

Villegas, V. M., Gold, A. S., Wildner, A. C., Ehlies, F. J., & Murray, T. G. (2014) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12277 · Cited by 4 · see citing works

Progress of Cancer Stem Cells in Retinoblastoma

Wang, N., & Ma, J. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x252989230921065809 · Cited by 3 · see citing works

New Hopes in Retinoblastoma Treatment

Turhan, S. A. (2014) · International Journal of Hematology and Oncology · doi:10.4999/uhod.14222 · Cited by 3 · see citing works

A role for Retinoblastoma 1 in hindbrain morphogenesis by regulating GBX family

Zhao, S., Wang, C., Luo, H., Li, F., Wang, Q., Xu, J., Huang, Z., Liu, W., & Zhang, W. (2024) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2024.03.008 · Cited by 3 · see citing works

Pomalidomide enhanced gemcitabine and nab-paclitaxel on pancreatic cancer bothin vitroandin vivo

Saito, N., Shirai, Y., Uwagawa, T., Horiuchi, T., Sugano, H., Haruki, K., Shiba, H., Ohashi, T., & Yanaga, K. K. (2018) · Oncotarget · doi:10.18632/oncotarget.24608 · Cited by 3 · see citing works

Retinal pigment epithelium exhibits gene expression and phagocytic activity alterations when exposed to retinoblastoma chemotherapeutics

Cerna-Chavez, R., Rozanska, A. L., Poretti, G. L., Benvenisty, N., Parulekar, M., & Lako, M. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109542 · Cited by 2 · see citing works

Retinoblastoma vulnerability to combined de novo and salvage pyrimidine ribonucleotide synthesis pharmacologic blockage

Mollick, T., Darekar, S. D., Dalarun, B., Plastino, F., Zhang, J., Fernández, A. P., Alkasalias, T., André, H., & Laı́n, S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23831 · Cited by 2 · see citing works

Molecular Landscape, Genomic Shift, and Prediction in the Neoadjuvant Setting of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Pons, L., Hernandez, L., Urbizu, A., Arnaldo, L., Rodríguez‐Martínez, P., Sanz, C., Muñoz-Mármol, A. M., Fernández, E., Felip, E., Quiroga, V., et al. (2025) · Modern Pathology · doi:10.1016/j.modpat.2025.100787 · Cited by 2 · see citing works

Exceptional response to cyclophosphamide and dexamethasone in a patient with metastatic castrate-resistant prostate cancer and RB1 mutation

Dohogne, B. J., Arif‐Tiwari, H., Bracamonte, E. R., & Babiker, H. M. (2020) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001025 · Cited by 2 · see citing works

UBE2C, Regulated by n6-methyladenosine Methyltransferase METTL3, Is an Oncogene in Retinoblastoma via PI3K-AKT Pathway

Chen, L., & Mei, S. (2025) · DNA and Cell Biology · doi:10.1089/dna.2025.0074 · Cited by 1 · see citing works

Pediatric Conjunctival and Intraocular Malignancies

Fries, P. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-60814-3_12 · Cited by 1 · see citing works

The Search for an Alternative Biomarker for the Detection and Diagnosis of Hepatocellular Carcinoma - The Journey So Far

Hussaini, I. M., Musa, B., & Bello, A. (2018) · Bioequivalence & Bioavailability International Journal · doi:10.23880/beba-16000115 · Cited by 1 · see citing works

Estudos sobre a expressão do Papilomavírus Humano (HPV): avaliação comparativa sobre lesões cervicais, sangue periférico e retinoblastomas.

Pessoa, N. D. S. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.87.2014.tde-07052014-090937 · Cited by 1 · see citing works

Inhibition of fatty acid synthase enhances therapeutic efficacy and delays acquired resistance to BRAF-targeted therapy in colorectal cancer

Geisen, M. E., Tessmann, J. W., Kelson, C. O., He, D., Wang, C., Faisal, A. S. M., Beswick, E. J., Baca, Y., Rock, S., Kolesar, J. M., et al. (2026) · Neoplasia · doi:10.1016/j.neo.2026.101283

Immunohistochemical Detection of early and late Human Papillomaviruses (HPV) proteins in Retinoblastoma tumorsPreprint

Pessoa, N. D. S., de Melo, T. C., Araldi, R. P., de Carvalho, R. F., Beçak, W., de Medeiros, J. W., Albuquerque, G. S., Gurgel, A. P. A. D., Hassan, R., Muniz, M. T., et al. (2020) · medRxiv · doi:10.1101/2020.07.16.20153882

Faculty Opinions recommendation of SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma.

Schefler, A. C. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732828753.793585164

Retinal pigment epithelium exhibits cell size, gene expression, and phagocytic activity alterations when exposed to retinoblastoma chemotherapeuticsPreprint

Cerna-Chavez, R., Rozanska, A. L., Poretti, G. L., Benvenisty, N., Parulekar, M., & Lako, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1886208/v1

Data from The Retinoblastoma Tumor Suppressor Modulates DNA Repair and Radioresponsiveness

Thangavel, C., Boopathi, E., Ciment, S., Liu, Y., Neill, R. O., Sharma, A. D., McMahon, S. B., Mellert, H. S., Addya, S., Ertel, A., et al. (2023) · doi:10.1158/1078-0432.c.6524742.v1

Pomalidomide enhanced gemcitabine and nab-paclitaxel on pancreatic cancer both in vitro and in vivo

斉藤, 庸. (n.d.) · Institutional Repositories DataBase (IRDB)

The Genetics of Retinoblastoma: Relevance to the Patient

Gallie, B. L., Dunn, J. M., Chan, H. S. L., Hamel, P. A., & Phillips, R. A. (1991) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)38079-8 · Cited by 65 · see citing works

Retinoblastoma: patients, tumors, gene and protein contribute to the understanding of cancer

Duckett, A., Dagnino, L., & Gallie, B. L. (2003) · Garland Science eBooks · doi:10.4324/9780203450383-13

Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies

Rathore, S., Verma, A., Ratna, R., Marwa, N., Ghiya, Y., Honavar, S. G., Tiwari, A., Das, S., & Varshney, A. (2023) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_3172_22 · Cited by 14 · see citing works

Retinoblastoma, Molecular Genetics of

Brown, V. D., & Gallie, B. L. (2006) · Encyclopedia of Molecular Cell Biology and Molecular Medicine · doi:10.1002/3527600906.mcb.200400098

Genetics in ophthalmology: molecular blueprints of retinoblastoma

Marković, L., Bukovac, A., Varošanec, A. M., Šlaus, N., & Pećina‐Šlaus, N. (2023) · Human Genomics · doi:10.1186/s40246-023-00529-w · Cited by 35 · see citing works